Literature DB >> 12869664

PharmGKB update: I. Genetic variants of the organic cation transporter 2 (OCT2, SLC22A2).

Maya K Leabman1, Conrad C Huang, Doug Stryke, Susan J Johns, Michiko Kawamoto, Thomas E Ferrin, Joseph DeYoung, Travis R Taylor, Melanie De La Cruz, Ira Herskowitz, Kathleen M Giacomini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12869664     DOI： 10.1124/pr.55.3.6

Source DB:  PubMed          Journal:  Pharmacol Rev        ISSN： 0031-6997            Impact factor:   25.468


× No keyword cloud information.
  3 in total

1.  Behavioral counseling and varenicline treatment for smoking cessation.

Authors:  Gary E Swan; Jennifer B McClure; Lisa M Jack; Susan M Zbikowski; Harold S Javitz; Sheryl L Catz; Mona Deprey; Julie Richards; Timothy A McAfee
Journal:  Am J Prev Med       Date:  2010-05       Impact factor: 5.043

2.  Impact of symptoms experienced by varenicline users on tobacco treatment in a real world setting.

Authors:  Abigail C Halperin; Timothy A McAfee; Lisa M Jack; Sheryl L Catz; Jennifer B McClure; T Mona Deprey; Julie Richards; Susan M Zbikowski; Gary E Swan
Journal:  J Subst Abuse Treat       Date:  2008-11-11

3.  Mood, side-effects and smoking outcomes among persons with and without probable lifetime depression taking varenicline.

Authors:  Jennifer B McClure; Gary E Swan; Lisa Jack; Sheryl L Catz; Susan M Zbikowski; Tim A McAfee; Mona Deprey; Julie Richards; Harold Javitz
Journal:  J Gen Intern Med       Date:  2009-02-24       Impact factor: 5.128
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.